Core Scientific gets upgrade from Roth as CoreWeave deal becomes less likely ⊕
found
You are not logged in so some information on this page has been withheld. To see more, please log in or sign up.
Roth Capital Partners believes that shares of Core Scientific could rally 27% from here.